Orthobiologics

Extremity Medical launched BioFuse, a next-gen viable cell bone graft for use in the foot, ankle, wrist and hand....

Bone Therapeutics completed patient recruitment for interim analysis in its Phase III trial of PREOB® for the treatment of hip...

Creative Medical Technology filed a patent application covering synergy between intradiscal stem cell injections and stimulation of blood vessel formation around...

Orthocell received confirmation that Ortho-ACI® Autologous Chondrocyte Implantation is included on the Australian Register of Therapeutic Goods....

SurGenTec was granted U.S. Patent No. 9,655,748, Bone Graft Delivery System and Method for Using Same, pertaining to the GRAFTGUN® device....

Anika Therapeutics enrolled the first patient in a supplemental Phase III trial evaluating CINGAL® viscosupplement for the treatment of knee...

NovaBone Products launched NovaBone IRM and NovaBone IRM MacroPOR to its portfolio of biologically-active bone graft substitutes....

Phase III study results demonstrated that Anika Therapeutics’ CINGAL® provided superior immediate and short term OA pain relief after injection...

BONESUPPORT enrolled the first patient in the pivotal IDE trial of CERAMENT G in the surgical repair of open diaphyseal...

Interim study results indicate that patients receiving Rotation Medical’s Bioinductive Implant to treat rotator cuff disease reported statistically significant improvement...